Last Close
563.70 $
Jul 7, 26
Market Cap
26.6 B $
Q1 2026 (TTM)
52-Week Range
%+94.1
%47.5
0.78
1.41
%-5.5
-%10.6
1M
+2.5%
3M
-0.4%
6M
+12.1%
YTD
+15.7%
1Y
+94.1%
3Y
+166.1%
Returns are computed from split-adjusted closes; dividends are not included.
Stock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.
UTHR last closed at 563.70 $ (Jul 7, 26). Price data is refreshed after every trading day.
United Therapeutics Corporation trades at a trailing-twelve-month P/E of 20.67. See the comparison tables on the Peers tab for the industry context.
United Therapeutics Corporation (UTHR) has a market capitalization of approximately 26.6 B $ as of the latest reported period.
Key peers of United Therapeutics Corporation include Merck KGaA, Laboratorios Farmaceuticos ROVI, Bausch Health Companies Inc, EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S., Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi. A detailed metric comparison is available on the Peers tab.
Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.